Lifeline Cell Technology, LLC researches, develops, manufactures, and markets purified primary human cells and optimized reagents for cell culture. It offers adipose, bladder, blood immune system, bone marrow, breast, cardiovascular, cornea, iPS validated fibroblasts, kidney, lung-airway, prostate, reproductive, skin, and umbilical cord tissue types; and cell types, including endothelial, epithelial, fibroblast, iPS validated fibroblasts, melanocytes, hematopoietic, smooth muscle, and human and non-human stem cells. The company also provides cell culture media, such as blood immune systems, endothelial-large and small vessel, epithelial, fibroblast, neuronal, smooth muscle, and human stem ce...
8415 Progress Drive
Frederick, MD 21701
Founded in 2001
Lifeline Cell Technology Expands Asian Distribution Network
Jul 16 14
International Stem Cell Corporation announced that its subsidiary, Lifeline Cell Technology, has expanded its sales network by adding a number of new distributors in Asia and Oceania. Lifeline Cell Technology (LCT) has expanded its overseas network by adding new distributors in several fast-growing territories including Korea, Taiwan, Australia, New Zealand and India. LCT develops, manufactures and commercializes over 130 human cell culture products. These products include frozen human adult or primary cells, adult stem cells and the reagents (called media) needed to grow, maintain and differentiate such cells. These human cell-based products are used by research scientists in pharmaceutical, academic and government research organizations to study human diseases and basic cell biology. LCT's products provide value and quality by eliminating the need for scientists to source their own cells or develop their own media. Strict quality assurance ensures a high level of consistency and standardization, which along with a high level of customer service, makes LCT's products the first choice for many scientists.